{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T11:20:50Z","timestamp":1783164050451,"version":"3.54.6"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011019","name":"Nemzeti Kutat\u00e1si Fejleszt\u00e9si \u00e9s Innov\u00e1ci\u00f3s Hivatal","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011019","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003827","name":"National Research Development and Innovation Office","doi-asserted-by":"publisher","award":["\\u00DANKP-23-3-I-SE-58"],"award-info":[{"award-number":["\\u00DANKP-23-3-I-SE-58"]}],"id":[{"id":"10.13039\/501100003827","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Translational Autoimmunity"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.jtauto.2026.100375","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T15:26:04Z","timestamp":1780068364000},"page":"100375","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Upregulated GLUT1 expression correlates with type I interferon activity and disease severity in cutaneous lupus erythematosus"],"prefix":"10.1016","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-4557-5223","authenticated-orcid":false,"given":"Laura Anna","family":"Bokor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Botond L.","family":"Szabolcs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2513-7786","authenticated-orcid":false,"given":"Zs\u00f3fia","family":"Kir\u00e1ly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Mohos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1gota","family":"Szepesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikt\u00f3ria","family":"Varga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Sebesty\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lajos V.","family":"Kem\u00e9ny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e9ter","family":"Holl\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernadett","family":"Hidv\u00e9gi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtauto.2026.100375_bib1","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.jaad.2010.02.008","article-title":"Quality of life in cutaneous lupus erythematosus","volume":"64","author":"Klein","year":"2011","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.jtauto.2026.100375_bib2","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s40257-023-00774-8","article-title":"Cutaneous Lupus erythematosus: an update on pathogenesis and future therapeutic directions","volume":"24","author":"Niebel","year":"2023","journal-title":"Am. J. Clin. Dermatol."},{"key":"10.1016\/j.jtauto.2026.100375_bib3","series-title":"Cutaneous Lupus Erythematosus","first-page":"53","article-title":"Classification of cutaneous lupus erythematosus","author":"Kuhn","year":"2005"},{"key":"10.1016\/j.jtauto.2026.100375_bib4","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jaut.2014.01.021","article-title":"The classification and diagnosis of cutaneous lupus erythematosus","volume":"48\u201349","author":"Kuhn","year":"2014","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jtauto.2026.100375_bib5","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.autrev.2012.08.019","article-title":"Cutaneous lupus erythematosus: first multicenter database analysis of 1002 patients from the European society of Cutaneous Lupus Erythematosus (EUSCLE)","volume":"12","author":"Biazar","year":"2013","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jtauto.2026.100375_bib6","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00281-015-0550-0","article-title":"Lupus erythematosus revisited","volume":"38","author":"Kuhn","year":"2016","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.jtauto.2026.100375_bib7","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1111\/j.1365-2133.2011.10272.x","article-title":"Cutaneous lupus erythematosus and the association with systemic lupus erythematosus: a population-based cohort of 1088 patients in Sweden","volume":"164","author":"Gronhagen","year":"2011","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jtauto.2026.100375_bib8","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1111\/j.0022-202X.2005.23889.x","article-title":"The CLASI (Cutaneous Lupus Erythematosus Disease Area and severity index): an outcome instrument for cutaneous lupus erythematosus","volume":"125","author":"Albrecht","year":"2005","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jtauto.2026.100375_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.915828","article-title":"Current concepts on pathogenic mechanisms and histopathology in cutaneous lupus erythematosus","volume":"9","author":"Fetter","year":"2022","journal-title":"Front. Med."},{"key":"10.1016\/j.jtauto.2026.100375_bib10","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/s41584-019-0272-0","article-title":"Cutaneous lupus erythematosus: new insights into pathogenesis and therapeutic strategies","volume":"15","author":"Wenzel","year":"2019","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.jtauto.2026.100375_bib11","doi-asserted-by":"crossref","DOI":"10.2340\/00015555-3587","article-title":"Myxovirus resistance protein A is a useful additional histological marker in suspected cutaneous lupus erythematosus","volume":"100","author":"Lambers","year":"2020","journal-title":"Acta Derm. Venereol."},{"key":"10.1016\/j.jtauto.2026.100375_bib12","doi-asserted-by":"crossref","first-page":"7776","DOI":"10.1128\/JVI.00546-06","article-title":"Induction of MxA gene expression by influenza A virus requires type I or type III interferon signaling","volume":"81","author":"Holzinger","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.jtauto.2026.100375_bib13","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/nri.2016.70","article-title":"A guide to immunometabolism for immunologists","volume":"16","author":"O'Neill","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jtauto.2026.100375_bib14","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1146\/annurev.ph.54.030192.004403","article-title":"Mammalian facilitative glucose transporter family: structure and molecular regulation","volume":"54","author":"Pessin","year":"1992","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.jtauto.2026.100375_bib15","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1002\/j.2040-4603.2012.tb00424.x","article-title":"Role of monosaccharide transport proteins in carbohydrate assimilation, distribution, metabolism, and homeostasis","volume":"2","author":"Cura","year":"2012","journal-title":"Compr. Physiol."},{"key":"10.1016\/j.jtauto.2026.100375_bib16","doi-asserted-by":"crossref","first-page":"3299","DOI":"10.4049\/jimmunol.1003613","article-title":"Cutting edge: distinct glycolytic and lipid oxidative metabolic programs are essential for effector and regulatory CD4+ T cell subsets","volume":"186","author":"Michalek","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.jtauto.2026.100375_bib17","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/j.1365-4632.2011.05299.x","article-title":"Glucose transporter member 1 is involved in UVB-induced epidermal hyperplasia by enhancing proliferation in epidermal keratinocytes","volume":"52","author":"Tochio","year":"2013","journal-title":"Int. J. Dermatol."},{"key":"10.1016\/j.jtauto.2026.100375_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2025.149383","article-title":"Glucose transporter-1 (GLUT-1) upregulation in vitiligo: a possible link to skin depigmentation","volume":"950","author":"Emam","year":"2025","journal-title":"Gene"},{"key":"10.1016\/j.jtauto.2026.100375_bib19","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines8020020","article-title":"2-deoxy-d-glucose ameliorates animal models of dermatitis","volume":"8","author":"Choi","year":"2020","journal-title":"Biomedicines"},{"key":"10.1016\/j.jtauto.2026.100375_bib20","first-page":"169","article-title":"The use of GLUT-1, Ki-67 and PCNA antibodies as immunohistochemical markers in histopathological differential diagnosis of psoriasis and chronic spongiotic dermatitits","volume":"35","author":"Kemal","year":"2021","journal-title":"Dokuz Eyl\u00fcl \u00dcniversitesi T\u0131p Fak\u00fcltesi Dergisi"},{"key":"10.1016\/j.jtauto.2026.100375_bib21","first-page":"8369","article-title":"Hypoxia-inducible factor-1alpha and glucose transporter 1 in the malignant transformation of oral lichen planus","volume":"10","author":"Wang","year":"2017","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.jtauto.2026.100375_bib22","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/ijd.14037","article-title":"Glucose transporter-1 (GLUT-1) expression in psoriasis: correlation with disease severity","volume":"57","author":"Hodeib","year":"2018","journal-title":"Int. J. Dermatol."},{"key":"10.1016\/j.jtauto.2026.100375_bib23","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/nature11003","article-title":"The cancer cell line Encyclopedia enables predictive modelling of anticancer drug sensitivity","volume":"483","author":"Barretina","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.jtauto.2026.100375_bib24","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov."},{"key":"10.1016\/j.jtauto.2026.100375_bib25","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"Gao","year":"2013","journal-title":"Sci. Signal."},{"key":"10.1016\/j.jtauto.2026.100375_bib26","doi-asserted-by":"crossref","first-page":"3861","DOI":"10.1158\/0008-5472.CAN-23-0816","article-title":"Analysis and visualization of longitudinal genomic and clinical data from the AACR project GENIE biopharma collaborative in cBioPortal","volume":"83","author":"de Bruijn","year":"2023","journal-title":"Cancer Res."},{"key":"10.1016\/j.jtauto.2026.100375_bib27","doi-asserted-by":"crossref","first-page":"2966","DOI":"10.1172\/JCI98219","article-title":"Fas ligand promotes an inducible TLR-dependent model of cutaneous lupus-like inflammation","volume":"128","author":"Mande","year":"2018","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.jtauto.2026.100375_bib28","doi-asserted-by":"crossref","first-page":"D991","DOI":"10.1093\/nar\/gks1193","article-title":"NCBI GEO: archive for functional genomics data sets--update","volume":"41","author":"Barrett","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jtauto.2026.100375_bib29","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1038\/s41467-018-03751-6","article-title":"Massive mining of publicly available RNA-seq data from human and mouse","volume":"9","author":"Lachmann","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jtauto.2026.100375_bib30","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1002\/art.40930","article-title":"European League against Rheumatism\/American college of Rheumatology classification criteria for systemic lupus erythematosus","volume":"71","author":"Aringer","year":"2019","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.jtauto.2026.100375_bib31","article-title":"Integrated analysis reveals the targets and mechanisms in immunosuppressive effect of mesalazine on ulcerative colitis","volume":"9","author":"Li","year":"2022","journal-title":"Front. Nutr."},{"key":"10.1016\/j.jtauto.2026.100375_bib32","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.intimp.2018.04.042","article-title":"Montelukast inhibits inflammatory response in rheumatoid arthritis fibroblast-like synoviocytes","volume":"61","author":"Dong","year":"2018","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.jtauto.2026.100375_bib33","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/s41422-020-0291-z","article-title":"Targeting immunometabolism as an anti-inflammatory strategy","volume":"30","author":"Palsson-McDermott","year":"2020","journal-title":"Cell Res."},{"key":"10.1016\/j.jtauto.2026.100375_bib34","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1046\/j.1523-1755.2003.00744.x","article-title":"Anti-inflammatory and immunomodulatory effects of statins","volume":"63","author":"Blanco-Colio","year":"2003","journal-title":"Kidney Int."},{"key":"10.1016\/j.jtauto.2026.100375_bib35","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/nrc.2016.77","article-title":"Reprogramming glucose metabolism in cancer: can it be exploited for cancer therapy?","volume":"16","author":"Hay","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jtauto.2026.100375_bib36","doi-asserted-by":"crossref","DOI":"10.1111\/obr.13621","article-title":"Multifaceted roles of T cells in obesity and obesity-related complications: a narrative review","volume":"24","author":"Qi","year":"2023","journal-title":"Obes. Rev."},{"key":"10.1016\/j.jtauto.2026.100375_bib37","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/6494795","article-title":"Role of T lymphocytes in type 2 diabetes and diabetes-associated inflammation","volume":"2017","author":"Xia","year":"2017","journal-title":"J. Diabetes Res."},{"key":"10.1016\/j.jtauto.2026.100375_bib38","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/nrrheum.2017.49","article-title":"Immunometabolism in early and late stages of rheumatoid arthritis","volume":"13","author":"Weyand","year":"2017","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.jtauto.2026.100375_bib39","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/s41575-022-00658-y","article-title":"The metabolic nature of inflammatory bowel diseases","volume":"19","author":"Adolph","year":"2022","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jtauto.2026.100375_bib40","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.semarthrit.2019.04.006","article-title":"Metabolism as a key regulator in the pathogenesis of systemic lupus erythematosus","volume":"48","author":"Takeshima","year":"2019","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.jtauto.2026.100375_bib41","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaa0835","article-title":"Normalization of CD4+ T cell metabolism reverses lupus","volume":"7","author":"Yin","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jtauto.2026.100375_bib42","doi-asserted-by":"crossref","first-page":"833","DOI":"10.3389\/fimmu.2019.00833","article-title":"Targeting T cell activation and Lupus Autoimmune phenotypes by inhibiting glucose transporters","volume":"10","author":"Li","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jtauto.2026.100375_bib43","article-title":"The role of UV-induced cutaneous matrix metalloproteinases and mi-RNAs in the pathogenesis of lupus erythematosus","volume":"10","author":"Ivanova","year":"2025","journal-title":"J Transl Autoimmun"},{"key":"10.1016\/j.jtauto.2026.100375_bib44","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.1037408","article-title":"Characterization of B cells in lupus erythematosus skin biopsies in the context of different immune cell infiltration patterns","volume":"9","author":"de Vos","year":"2022","journal-title":"Front. Med."},{"key":"10.1016\/j.jtauto.2026.100375_bib45","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S1074-7613(02)00323-0","article-title":"The CD28 signaling pathway regulates glucose metabolism","volume":"16","author":"Frauwirth","year":"2002","journal-title":"Immunity"},{"key":"10.1016\/j.jtauto.2026.100375_bib46","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.cmet.2014.05.004","article-title":"The glucose transporter Glut1 is selectively essential for CD4 T cell activation and effector function","volume":"20","author":"Macintyre","year":"2014","journal-title":"Cell Metab."},{"key":"10.1016\/j.jtauto.2026.100375_bib47","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.4049\/jimmunol.1800002","article-title":"Myeloid Slc2a1-Deficient murine model revealed macrophage activation and metabolic phenotype are fueled by GLUT1","volume":"202","author":"Freemerman","year":"2019","journal-title":"J. Immunol."},{"key":"10.1016\/j.jtauto.2026.100375_bib48","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.cmet.2017.08.012","article-title":"Cell-Intrinsic glycogen metabolism supports early glycolytic reprogramming required for dendritic cell immune responses","volume":"26","author":"Thwe","year":"2017","journal-title":"Cell Metab."},{"key":"10.1016\/j.jtauto.2026.100375_bib49","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/s41591-018-0003-0","article-title":"Differential glucose requirement in skin homeostasis and injury identifies a therapeutic target for psoriasis","volume":"24","author":"Zhang","year":"2018","journal-title":"Nat Med"},{"key":"10.1016\/j.jtauto.2026.100375_bib50","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/s41584-025-01318-6","article-title":"Cutaneous lupus erythematosus - from pathogenesis to targeted therapy","volume":"21","author":"Klein","year":"2025","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.jtauto.2026.100375_bib51","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1016\/j.jid.2017.03.018","article-title":"Immunostimulatory endogenous nucleic acids drive the lesional inflammation in cutaneous lupus erythematosus","volume":"137","author":"Scholtissek","year":"2017","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jtauto.2026.100375_bib52","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1002\/art.21034","article-title":"Ultraviolet radiation-induced injury, chemokines, and leukocyte recruitment: an amplification cycle triggering cutaneous lupus erythematosus","volume":"52","author":"Meller","year":"2005","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jtauto.2026.100375_bib53","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/path.1721","article-title":"Enhanced type I interferon signalling promotes Th1-biased inflammation in cutaneous lupus erythematosus","volume":"205","author":"Wenzel","year":"2005","journal-title":"J. Pathol."},{"key":"10.1016\/j.jtauto.2026.100375_bib54","doi-asserted-by":"crossref","first-page":"7489","DOI":"10.1038\/s41467-022-35209-1","article-title":"Single-cell sequencing shows cellular heterogeneity of cutaneous lesions in lupus erythematosus","volume":"13","author":"Zheng","year":"2022","journal-title":"Nat. Commun."}],"container-title":["Journal of Translational Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589909026000286?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589909026000286?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T10:47:16Z","timestamp":1783162036000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589909026000286"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":54,"alternative-id":["S2589909026000286"],"URL":"https:\/\/doi.org\/10.1016\/j.jtauto.2026.100375","relation":{},"ISSN":["2589-9090"],"issn-type":[{"value":"2589-9090","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Upregulated GLUT1 expression correlates with type I interferon activity and disease severity in cutaneous lupus erythematosus","name":"articletitle","label":"Article Title"},{"value":"Journal of Translational Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtauto.2026.100375","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100375"}}